Developed and taught several course for the Graduate SchoolGRAD 750: The Translation of Scientific Research into Societal BenefitGRAD 751: Consulting FundamentalsGRAD 755: Fundamentals of Technology CommercializationGRAD 756: Research to Revenue - Introduction to University StartupsGRAD 717: Introduction to Entrepreneurship and the Entrepreneurial MindsetGRAD 718: Start the Startup - Testing and Validating a New Business Idea

KickStart Venture Services is a program to help facilitate and accelerate startup companies spinning out of the University. As part of the Office of Commercialization and Economic Development (OCED), the program focuses on biomedical and life science technologies (drugs, devices, diagnostics, tools) and how to bring those technologies to the marketplace through venture formation.

Developed and taught the 2nd year MBA course Healthcare Entrepreneurship (MBA 837), an introduction to life science startups. This course focused on the elements of successfully launching a life science venture. Currently teaching StartupUNC (MBA 848), a course focusing on the lean startup methodology for students exploring the feasibility of their startup idea.

Equiti Foods is a mission-driven food and wellness company

Metabolon is a metabolomics technology company. I refined the strategy of the service business to move beyond the early adoption phase. By focusing on vertical markets and supporting key applications, broader adoption was realized. In addition, I formulated the product strategy for the company's two leading diagnostic tests (pre-diabetes, prostate cancer), focusing on un-met needs, competition, and reimbursement.

Heleos Advisors was a life science tools and technologies consulting group. We specialized in early to mid stage compaies with high-impact technologies. Services ranged from product strategy to tactical marketing to sales force development.

Deerac Fluidics, based in Dublin, Ireland, was in the early stages of commercializing a nanoliter liquid dispensing techology. I developed their go-to-market strategy for attacking key markets. In addition, I established their North American presence through hiring and managing the NA sales team and developing a strategic marketing plan.

DataCentric Automation (DCA), a division of Titan Corporation, had developed software and instrumentation for automated x-ray crystallography. DCA was considered a non-strategic asset and I was hired to increase revenue to make the unit more attractive to an outside buyer. I put together a commercial team and oversaw the purchase of DCA by Kendro, now part of ThermoFisher.

Catalysta Partners, now part of Hatteras Venture Partners, was an early stage VC company. As partner, I evalutated the life science deal flow and served as senior management of portfolio companies. During this time, I helped to found and run Phase Bioscience.

Phase Bioscience was a start-up company based on novel polymer technology developed at Duke University. The polymers were able to rapidly and reversibly undergo heat-induced phase transitions. I helped found the company, identify the key application, raise its seed round, secure SBIR funding, and establish partnerships.

Cartesian Technologies commercialized a nanoliter dispensing and printing technologies. As part of the founding team, I worked across many aspects of the company from product development to sales. The company was successfully acquired by Genomic Solutions in Dec 2001

Worked on developing novel technologies for internal use in drug discovery. Projects included novel bioanalytical sytems employing capillary electrophoresis, a combinatorial chemisty system for building chemical libraries on plastic sheets, and a high-resolution imaging system for high-throughput screening.

Worked on various aspects of capillary electrophoresis instrumentation, resulting in the successful transfer and launch HP's first CE instrument.